圣兆药物、海正药业在浙江成立新公司

Core Viewpoint - Zhejiang Lingyu Pharmaceutical Co., Ltd. has been established with a registered capital of 100 million yuan, focusing on drug production, wholesale, and import-export activities [1] Company Summary - The legal representative of Zhejiang Lingyu Pharmaceutical Co., Ltd. is Zhang Hongyao [1] - The company is co-owned by Zhejiang Shengzhao Pharmaceutical Technology Co., Ltd. and Haizheng Pharmaceutical (stock code: 600267) [1] Industry Summary - The establishment of Zhejiang Lingyu Pharmaceutical indicates ongoing investment and development in the pharmaceutical sector, particularly in drug production and distribution [1]